BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 18430965)

  • 21. Effects of testosterone administration in human immunodeficiency virus-infected women with low weight: a randomized placebo-controlled study.
    Dolan S; Wilkie S; Aliabadi N; Sullivan MP; Basgoz N; Davis B; Grinspoon S
    Arch Intern Med; 2004 Apr; 164(8):897-904. PubMed ID: 15111377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
    Allan CA; Strauss BJ; Burger HG; Forbes EA; McLachlan RI
    J Clin Endocrinol Metab; 2008 Jan; 93(1):139-46. PubMed ID: 17940111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.
    Strawford A; Barbieri T; Van Loan M; Parks E; Catlin D; Barton N; Neese R; Christiansen M; King J; Hellerstein MK
    JAMA; 1999 Apr; 281(14):1282-90. PubMed ID: 10208143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of a randomized trial to determine the optimum protein intake to preserve lean body mass and to optimize response to a promyogenic anabolic agent in older men with physical functional limitation.
    Bhasin S; Apovian CM; Travison TG; Pencina K; Huang G; Moore LL; Campbell WW; Howland A; Chen R; Singer MR; Shah M; Eder R; Schram H; Bearup R; Beleva YM; McCarthy AC; Li Z; Woodbury E; McKinnon J; Storer TW; Basaria S
    Contemp Clin Trials; 2017 Jul; 58():86-93. PubMed ID: 28483498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.
    Grinspoon S; Corcoran C; Askari H; Schoenfeld D; Wolf L; Burrows B; Walsh M; Hayden D; Parlman K; Anderson E; Basgoz N; Klibanski A
    Ann Intern Med; 1998 Jul; 129(1):18-26. PubMed ID: 9652995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss.
    Montano M; Flanagan JN; Jiang L; Sebastiani P; Rarick M; LeBrasseur NK; Morris CA; Jasuja R; Bhasin S
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2793-802. PubMed ID: 17440010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do the effects of testosterone on muscle strength, physical function, body composition, and quality of life persist six months after treatment in intermediate-frail and frail elderly men?
    O'Connell MD; Roberts SA; Srinivas-Shankar U; Tajar A; Connolly MJ; Adams JE; Oldham JA; Wu FC
    J Clin Endocrinol Metab; 2011 Feb; 96(2):454-8. PubMed ID: 21084399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effects of nandrolone and testosterone in adult male HIV patients with AIDS wasting syndrome (AWS): a randomized, double-blind, placebo-controlled trial.
    Sardar P; Jha A; Roy D; Majumdar U; Guha P; Roy S; Banerjee R; Banerjee AK; Bandyopadhyay D
    HIV Clin Trials; 2010; 11(4):220-9. PubMed ID: 20974577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.
    Bhasin S; Storer TW; Berman N; Callegari C; Clevenger B; Phillips J; Bunnell TJ; Tricker R; Shirazi A; Casaburi R
    N Engl J Med; 1996 Jul; 335(1):1-7. PubMed ID: 8637535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.
    Miller K; Corcoran C; Armstrong C; Caramelli K; Anderson E; Cotton D; Basgoz N; Hirschhorn L; Tuomala R; Schoenfeld D; Daugherty C; Mazer N; Grinspoon S
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2717-25. PubMed ID: 9709937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testosterone dose-response relationships in healthy young men.
    Bhasin S; Woodhouse L; Casaburi R; Singh AB; Bhasin D; Berman N; Chen X; Yarasheski KE; Magliano L; Dzekov C; Dzekov J; Bross R; Phillips J; Sinha-Hikim I; Shen R; Storer TW
    Am J Physiol Endocrinol Metab; 2001 Dec; 281(6):E1172-81. PubMed ID: 11701431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of transdermal testosterone administration on insulin sensitivity, fat mass and distribution, and markers of inflammation and thrombolysis in human immunodeficiency virus-infected women with mild to moderate weight loss.
    Herbst KL; Calof OM; Hsia SH; Sinha-Hikim I; Woodhouse LJ; Buchanan TA; Bhasin S
    Fertil Steril; 2006 Jun; 85(6):1794-802. PubMed ID: 16759927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
    Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of models to predict anabolic response to testosterone administration in healthy young men.
    Woodhouse LJ; Reisz-Porszasz S; Javanbakht M; Storer TW; Lee M; Zerounian H; Bhasin S
    Am J Physiol Endocrinol Metab; 2003 May; 284(5):E1009-17. PubMed ID: 12517741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DHEA in elderly women and DHEA or testosterone in elderly men.
    Nair KS; Rizza RA; O'Brien P; Dhatariya K; Short KR; Nehra A; Vittone JL; Klee GG; Basu A; Basu R; Cobelli C; Toffolo G; Dalla Man C; Tindall DJ; Melton LJ; Smith GE; Khosla S; Jensen MD
    N Engl J Med; 2006 Oct; 355(16):1647-59. PubMed ID: 17050889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized pilot study of monthly cycled testosterone replacement or continuous testosterone replacement versus placebo in older men.
    Sheffield-Moore M; Dillon EL; Casperson SL; Gilkison CR; Paddon-Jones D; Durham WJ; Grady JJ; Urban RJ
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1831-7. PubMed ID: 21865352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study.
    Bouloux PM; Legros JJ; Elbers JM; Geurts TB; Kaspers MJ; Meehan AG; Meuleman EJ;
    Aging Male; 2013 Jun; 16(2):38-47. PubMed ID: 23581697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: a randomized, double-blind, placebo-controlled study.
    Miller KK; Biller BM; Beauregard C; Lipman JG; Jones J; Schoenfeld D; Sherman JC; Swearingen B; Loeffler J; Klibanski A
    J Clin Endocrinol Metab; 2006 May; 91(5):1683-90. PubMed ID: 16478814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.